A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients

ALTality, Inc.20 enrolled

Overview

This is a pilot study to evaluate the feasibility of SpellBound's AR (augmented reality)-enabled scavenger hunt use among 20 pediatric cancer patients undergoing surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Pediatric Cancer Surgery

Interventions

ARISE with ARDEVICE

An augmented reality game for mobile devices with AR experiences enabled

ARISE without ARDEVICE

An augmented reality game for mobile devices with AR experiences disabled as an control

Eligibility

Sex: ALLMin age: 3 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Ages 3-18 2. English speaking parents/legal guardians and patients 3. Undergoing major surgery for cancer requiring postoperative hospitalization defined as ≥2 hours of duration of surgery and requiring postoperative hospital admission of at least one night 4. Expected to be prescribed postoperative inpatient opioids 5. Have never taken opioids or have had no daily opioid use within the last 30 days 6. Sufficient cognitive capacity to comprehend and interact with the game. This is defined as ability to utilize mobile technology (use iPad with or without assistance) and activate and respond to AR experiences within the app as determined by the clinician. 7. Both child and a legal guardian are willing and able to provide informed consent. Exclusion Criteria: 1. History of documented peripheral neuropathy secondary to cancer treatment 2. Inability to demonstrate an understanding of the game from English instructions 3. Have previous played the ARISETM digital scavenger hunt game 4. Any additional concerns based on the study physicians' assessments

Locations (2)

M.D. Anderson Cancer Center

Houston, Texas, United States

Texas Children's Hospital

Houston, Texas, United States

Outcomes

Primary Outcomes

Percentage of patients who receive the AR game who are able to initiate the game and activate any targets with 1% error rate

Success defined as at least 80% of patients who receive the AR game being able to initiate the game and activate any targets with 1% error rate